Results 51 to 60 of about 8,658 (136)
Use of gevokizumab for the treatment of Behçet's disease
, 2013 Introduction: Behçet's disease is a rare systemic autoinflammatory disorder of unknown aetiology. The hetereogenous clinical presentation makes treatment with standardised regimes a challenge and routine immunosuppressant therapies may render patients ...
McDermott, Michael F. +5 more
core +1 more source
Doença de Behçet: relato de 2 casos com manifestações neurológicas. [PDF]
, 1983 Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Clínica Médica, Curso de Medicina, Florianópolis ...
Dalacorte, Jonas
core
Haemostasis in Patients with Behçet's Disease
, 2000 Aim to determine whether Behçet's disease affects haemostatic function.Setting University Hospital, Turkey. Patients one hundred and twenty-seven consecutive patients with Behçet's disease, 34 of whom with a history of vascular involvement.
Demirer, S. +13 more
core +1 more source
Reproxalap ‐ A Novel Treatment Option for Allergic Conjunctivitis – A Comprehensive Narrative Review
Health Science Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background and Aims Allergic conjunctivitis is a prevalent, immune‐mediated hypersensitivity disorder of the ocular surface affecting 10%–20% of the global population. Current therapeutic options, while effective to some extent, are often limited by side effects and inconsistent efficacy.
Sanila Mughal +7 more
wiley +1 more source
Epidemiological and clinical features of BehÇet's disease in Korea
, 1997 Behçet's disease occurs with a high prevalence in the Far East including Korea. In this report we inspected 1,155 patients with Behçet's disease and collected information concerning the clinical and epidemiologic features of Behçet's disease in Korea. In
방동식
core +1 more source
Laryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.ABSTRACT Objective To provide a preliminary symptom‐based and standardized single‐consistency FEES screening assessment of swallowing in adults with Behçet disease using the Eating Assessment Tool‐10 (EAT‐10) and fiberoptic endoscopic evaluation of swallowing (FEES).
Emre Demirel +2 more
wiley +1 more source
Adalimumab for sight-threatening uveitis in Behçet's disease
, 2006 AIMS: To describe the clinical outcome of three patients with Behçet's disease maintained on infliximab who were switched to adalimumab therapy. METHODS: Case note review. Main outcome measure was recurrence of uveitis.
Situnayake, Rohan +3 more
core +1 more source
Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang +3 more
wiley +1 more source
PECU: A multicenter study on pediatric patients with cold‐induced urticaria
Pediatric Allergy and Immunology, Volume 37, Issue 6, June 2026.Abstract Background Cold‐induced urticaria (ColdU) is a rare chronic inducible urticaria that can cause systemic reactions, including cold‐induced anaphylaxis (ColdA), but pediatric data are limited. The aim of this study was to evaluate the clinical characteristics, comorbidities, management approaches, risk of anaphylaxis, and long‐term course of ...
Betul Gemici Karaaslan +59 more
wiley +1 more source
Alveolar proteinosis in Behçet's disease
, 2010 A 51-year-old man with Behçet's disease complained of fever, dry cough and dyspnea during exertion. Chest CT showed ground glass opacities with interstitial septal thickening in both lungs.
Imran Ozdemir +9 more
core +1 more source